- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00446914
High Blood Pressure Strategy (HBPS)
August 18, 2008 updated by: Heart and Stroke Foundation of Ontario
High Blood Pressure Strategy: Hypertension Management Initiative Study
This program developed by the HSFO aims at helping people of Ontario and their primary healthcare providers better diagnose, manage and control high blood pressure.
The High Blood Pressure Strategy brings together healthcare providers and patients to improve the way in which family doctors, nurse practitioners and pharmacists work together and with patients towards improved control of high blood pressure through the use of evidence-informed tools combined with local systems change.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Approximately 5,000 patients will participate in the study at 11 family practice sites throughout Ontario.
Each of the 11 clinic sites will be randomised to either intervention or delayed intervention 9 months later.
The intervention is a systems change involving interprofessional education and management tools to bring together physicians, nurses and pharmacists with the patient.
Patients will be monitored by their family doctor or nurse practitioner at scheduled follow-up visits during a period of 36 months for an effect of the intervention over time on the patient's blood pressure.
Study Type
Interventional
Enrollment (Anticipated)
5000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M4P1E4
- Recruiting
- Heart and Stroke Foundation of Ontario
-
Contact:
- Margaret Moy Lum-Kwong, BSc.N, MBA, CHE
- Phone Number: 445 416-489-7111
- Email: moylumkwong@hsf.on.ca
-
Contact:
- Shirley Von Sychowski, BA, MA
- Phone Number: 339 416-489-7111
- Email: svsychowski@hsf.on.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults aged 18 years or older
- History of elevated BP reading or primary hypertension diagnosis
Exclusion Criteria:
- Major mental health illness of cognitive impairment
- Language barrier (unable to speak or read English)
- Lives in a long-term care home
- Secondary hypertension
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Blood Pressure
Time Frame: 36 months
|
36 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Sheldon W Tobe, MD, FRCP(C), Sunnybrook Health Sciences Centre
- Principal Investigator: Margaret Moy Lum-Kwong, BSc.N., MBA, CHE, Heart and Stroke Foundation of Ontario
- Principal Investigator: Shirley Von Sychowski, BA, MA, Heart and Stroke Foundation of Ontario
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2007
Primary Completion (Anticipated)
January 1, 2010
Study Completion (Anticipated)
January 1, 2010
Study Registration Dates
First Submitted
March 12, 2007
First Submitted That Met QC Criteria
March 12, 2007
First Posted (Estimate)
March 13, 2007
Study Record Updates
Last Update Posted (Estimate)
August 19, 2008
Last Update Submitted That Met QC Criteria
August 18, 2008
Last Verified
August 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 474-2006
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
Clinical Trials on Systems Change (High Blood Pressure Strategy)
-
National University Hospital, SingaporeRecruitingOut-Of-Hospital Cardiac Arrest (OHCA)Singapore
-
Seoul National University HospitalRecruitingMajor Non-cardiac SurgeryKorea, Republic of
-
State University of New York - Upstate Medical...WithdrawnCritical Illness | Blood Pressure | HypovolemiaUnited States
-
University of Maryland, BaltimoreTerminated
-
Beth Israel Deaconess Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)CompletedAcute Respiratory Distress SyndromeUnited States, Canada
-
Tulane UniversityBeijing Tiantan HospitalWithdrawn
-
Yale UniversityCompletedBlood PressureUnited States
-
Johns Hopkins UniversityAgency for Healthcare Research and Quality (AHRQ)CompletedHigh Blood PressureUnited States
-
Assistance Publique - Hôpitaux de ParisRecruitingCerebrovascular DisordersFrance
-
Great Ormond Street Hospital for Children NHS Foundation...Imperial College London; Barts & The London NHS Trust; Intensive Care National...CompletedFIRST-line Support for Assistance in Breathing in Children (FIRST-ABC) Feasibility Study (FIRST-ABC)Hypoxia | Respiratory Acidosis | Moderate/Severe Respiratory DistressUnited Kingdom